AHA sessions to feature cutting-edge science, anticipated tr
Two of the most anticipated highlights from AHA 2016 are the ART trial, which will present the 5-year results of the largest randomized trial of bilateral mammary artery CABG compared with standard single mammary artery grafting plus vein grafts and the FUTURE trial, a randomized, controlled, multicenter study comparing fractional flow reserve-guided therapeutic management with conventional therapeutic management in patients with multivessel CAD...

http://www.healio.com/cardiology/practice-management/news/online/{cb368978-9fb9-47da-b781-99417cd8f34e}/aha-sessions-to-feature-cutting-edge-science-anticipated-trials
Like
Comment
Share